部位 | ICD-O-3 | 合計 | 男性 | 女性 | |||
---|---|---|---|---|---|---|---|
件数 | % | 件数 | % | 件数 | % | ||
全部位 | 3,344 | 100.0% | 1,839 | 100.0% | 1,505 | 100.0% | |
頭頸部 | C00-C14 C30-C32 | 275 | 8.2% | 192 | 10.4% | 83 | 5.5% |
食道 | C15 | 226 | 6.8% | 200 | 10.9% | 26 | 1.7% |
胃 | C16 | 262 | 7.8% | 200 | 10.9% | 62 | 4.1% |
大腸 | C18-C20 | 228 | 6.8% | 138 | 7.5% | 90 | 6.0% |
( 結腸 ) | C18 | 136 | 4.1% | 78 | 4.2% | 58 | 3.9% |
( 直腸S状結腸移行部、直腸) | C19-C20 | 92 | 2.8% | 60 | 3.3% | 32 | 2.1% |
膵 | C25 | 163 | 4.9% | 93 | 5.1% | 70 | 4.7% |
気管、気管支及び肺 | C33-C34 | 250 | 7.5% | 180 | 9.8% | 70 | 4.7% |
乳房 | C50 | 311 | 9.3% | 2 | 0.1% | 309 | 20.5% |
子宮 | C53-C55 | 206 | 6.2% | - | - | 206 | 13.7% |
( 子宮頚 ) | C53 | 99 | 3.0% | - | - | 99 | 6.6% |
( 子宮体部 ) | C54 | 107 | 3.2% | - | - | 107 | 7.1% |
( 子宮NOS ) | C55 | 0 | 0.0% | - | - | 0 | 0.0% |
前立腺 | C61 | 195 | 5.8% | 195 | 10.6% | - | - |
髄膜、脳、脊髄、脳神経及びその他の中枢神経系 | C70-C72 | 164 | 4.9% | 77 | 4.2% | 87 | 5.8% |
悪性リンパ腫 | M959-M972 | 143 | 4.3% | 77 | 4.2% | 66 | 4.4% |
その他(100件未満) | 921 | 27.5% | 485 | 26.4% | 436 | 29.0% |
※4 登録症例が年間100例に満たないものはその他に含みます。
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 96.9% | 100.0% | 80.0% | 29.4% | 100.0% | 0.0% | 91.1% |
手術 | 33.7% | 100.0% | 80.0% | 29.4% | 7.1% | 0.0% | 36.9% |
(うち、体腔鏡的治療) | 28.8% | 30.0% | 20.0% | 0.0% | 7.1% | 0.0% | 24.8% |
内視鏡的治療 | 66.3% | 0.0% | 0.0% | 5.9% | 92.9% | 0.0% | 57.0% |
放射線療法 | 0.0% | 0.0% | 0.0% | 17.6% | 0.0% | 0.0% | 1.4% |
化学療法 | 4.3% | 80.0% | 50.0% | 82.4% | 7.1% | 0.0% | 16.4% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 100.0% | 97.8% | 100.0% | 94.1% | 76.5% | 97.4% | 0.0% | 95.1% |
手術 | 6.3% | 84.8% | 100.0% | 94.1% | 88.2% | 15.8% | 0.0% | 60.1% |
(うち、体腔鏡的治療) | 6.3% | 67.4% | 55.6% | 58.8% | 23.5% | 10.5% | 0.0% | 38.5% |
内視鏡的治療 | 93.8% | 17.4% | 0.0% | 0.0% | 0.0% | 84.2% | 0.0% | 38.5% |
放射線療法 | 0.0% | 2.2% | 11.1% | 41.2% | 0.0% | 0.0% | 0.0% | 6.3% |
化学療法 | 0.0% | 13.0% | 22.2% | 58.8% | 70.6% | 5.3% | 0.0% | 22.4% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 65.5% | 40.0% | 50.0% | 50.0% | 100.0% | 42.9% | 55.6% |
手術 | 65.5% | 33.3% | 50.0% | 0.0% | 100.0% | 42.9% | 52.4% |
(うち、体腔鏡的治療) | 27.6% | 13.3% | 0.0% | 0.0% | 50.0% | 0.0% | 17.5% |
内視鏡的治療 | 0.0% | 6.7% | 0.0% | 50.0% | 0.0% | 0.0% | 3.2% |
放射線療法 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
化学療法 | 31.0% | 60.0% | 50.0% | 100.0% | 0.0% | 71.4% | 46.0% |
TAE | 27.6% | 60.0% | 37.5% | 0.0% | 0.0% | 0.0% | 31.7% |
レーザー等治療 | 17.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 7.9% |
(重複あり)
Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|
手術または内視鏡的治療の割合 | 65.2% | 22.2% | 12.2% | 5.7% | 100.0% | 0.0% | 40.0% |
手術 | 65.2% | 22.2% | 12.2% | 5.7% | 100.0% | 0.0% | 40.0% |
(うち、体腔鏡的治療) | 55.1% | 11.1% | 9.8% | 0.0% | 82.6% | 0.0% | 31.8% |
内視鏡的治療 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
放射線療法 | 29.0% | 33.3% | 68.3% | 41.5% | 0.0% | 0.0% | 37.4% |
化学療法 | 10.1% | 22.2% | 80.5% | 58.5% | 13.0% | 0.0% | 39.0% |
その他 | 0.0% | 0.0% | 0.0% | 1.9% | 0.0% | 0.0% | 0.5% |
(重複あり)
0期 | Ⅰ期 | Ⅱ期 | Ⅲ期 | Ⅳ期 | 不明 | 空欄 | 合計 | |
---|---|---|---|---|---|---|---|---|
手術の割合 | 100.0% | 96.9% | 94.4% | 66.7% | 4.0% | 100.0% | 0.0% | 81.9% |
放射線療法 | 26.3% | 42.2% | 36.1% | 41.7% | 8.0% | 50.0% | 0.0% | 32.8% |
化学療法 | 5.3% | 32.8% | 50.0% | 75.0% | 56.0% | 0.0% | 0.0% | 36.2% |
内分泌療法 | 26.3% | 65.6% | 63.9% | 41.7% | 32.0% | 50.0% | 0.0% | 50.3% |
(重複あり)